alovudine has been researched along with Cancer of Prostate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berndorff, D; Chang, E; Cheng, Z; Ellinghaus, P; Gambhir, SS; Gekeler, V; Liu, H; Liu, S; Unterschemmann, K | 1 |
| Ai, H; Chen, S; Cheng, Z; Jiang, X; Li, X; Lu, H; Qing, H; Wei, R; Wu, C; Xu, G | 1 |
| Emonds, KM; Mortelmans, L; Mottaghy, FM; Swinnen, JV | 1 |
| Dence, C; Fujibayashi, Y; Hasegawa, Y; Kiyono, Y; Kobayashi, M; Oyama, N; Ponde, DE; Welch, MJ; Yokoyama, O | 1 |
| Calaminus, C; Duchamp, O; Honndorf, VS; Judenhofer, MS; Kukuk, D; Machulla, HJ; Pichler, BJ; Quintanilla-Martinez, L; Raguin, O; Reischl, G; Schönberger, T; Wiehr, S | 1 |
| Dence, C; Kim, J; Oyama, N; Ponde, DE; Tai, YC; Welch, MJ | 1 |
1 review(s) available for alovudine and Cancer of Prostate
| Article | Year |
|---|---|
Molecular imaging of prostate cancer.
Topics: Animals; Antigens, Neoplasm; Bombesin; Cell Line, Tumor; Choline; Dideoxynucleosides; Dihydrotestosterone; Fluorodeoxyglucose F18; GPI-Linked Proteins; Humans; Male; Membrane Glycoproteins; Molecular Diagnostic Techniques; Neoplasm Proteins; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2009 |
5 other study(ies) available for alovudine and Cancer of Prostate
| Article | Year |
|---|---|
18F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Nude; Nitroimidazoles; Oxadiazoles; Positron-Emission Tomography; Prostatic Neoplasms; Pyrazoles; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Misonidazole; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Early response assessment in prostate carcinoma by ¹⁸F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Docetaxel; Drug Evaluation, Preclinical; Flow Cytometry; Humans; Immunohistochemistry; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Taxoids; Time Factors; Treatment Outcome | 2011 |
Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models.
Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Choline; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Mice; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Transplantation, Heterologous | 2011 |
Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.
Topics: Androgens; Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Dideoxynucleosides; Diethylstilbestrol; Male; Metabolic Clearance Rate; Mice; Mice, Nude; Neoplasm Staging; Orchiectomy; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 2004 |